SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,593.24 -1,045.46
( -1.44%)

Global Indices

Nasdaq

51,245.91 45.04
(0.09%)

Dow Jones

7,786.38 -36.39
(-0.47%)

Hang Seng

69,343.08 -692.63
(-0.99%)

Nikkei 225

10,441.54 -16.96
(-0.16%)

Forex

USD-INR

96.37 0.10
(0.10%)

EUR-INR

108.33 0.45
(0.42%)

GBP-INR

127.68 0.44
(0.34%)

JPY-INR

0.61 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Supriya Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543434

INE07RO01027

148.8184507

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUPRIYA

34.92

6938.82

EPS(TTM)

Face Value()

Div & Yield %

24.69

0.12

Back

le lavoir ltd

Aksh Optifibre reports consolidated net profit of Rs 4.71 crore in the June 2026 quarter

Aug 15,2026

Net profit of Aksh Optifibre reported to Rs 4.71 crore in the quarter ended June 2026 as against net loss of Rs 6.46 crore during the previous quarter ended June 2025. Sales rose 85.39% to Rs 49.87 crore in the quarter ended June 2026 as against Rs 26.90 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	49.87	26.90	85
OPM %	20.67	-3.64	-
PBDT	7.98	-3.69	LP
PBT	5.32	-6.70	LP
NP	4.71	-6.46	LP

71,593.24 -1,045.46 ( -1.44%)

51,245.91 45.04 (0.09%)

7,786.38 -36.39 (-0.47%)

69,343.08 -692.63 (-0.99%)

10,441.54 -16.96 (-0.16%)

96.37 0.10 (0.10%)

108.33 0.45 (0.42%)

127.68 0.44 (0.34%)

0.61 0.00 (0.01%)